Analytics

Analyzing drugs adverse effects by assessing drug molecular mechanisms of action, patient genetics and clinical characteristics.

Largest and daily updated transcriptomic and genomic biomarkers database of clinically actionable molecular targets in the tumor.

Automated match with clinically and genetically similar patient cohorts and case studies across the largest database of clinical trials results.

Utilizing daily updated molecular mechanism of action database of all available treatment options to ensure  therapy selection for advance clinical cases.

Prioritizing treatment options based on the patient molecular profile within FDA approved/NCCN recommended treatment options.

Predicting the risk of inherited diseases based on germline mutations analysis of normal tissue.

BostonGene helps to select relevant treatment options for each patient based on their clinical parameters, treatment history, and tumor molecular profiling and align those with NCCN recommendations.

Automated search of available clinical trials and matching patient inclusion/exclusion clinical and genetic criteria using machine learning algorithms.

Collected, uniformly processed and annotated NGS database of different cancer types.

BostonGene provides support in publication writing and encourages joint publications of scientific findings and analyses.